本文選題：神經(jīng)心理學(xué) + 神經(jīng)生長(zhǎng)因子��； 參考：《安徽醫(yī)科大學(xué)》2013年碩士論文

【摘要】：據(jù)報(bào)道全世界每年有約10萬(wàn)人死于吸毒，我國(guó)目前登記在冊(cè)的吸毒人員有100萬(wàn)左右。嗎啡、海洛因等毒品被人們反復(fù)使用后，會(huì)產(chǎn)生軀體依賴(lài)性和精神依賴(lài)性，軀體依賴(lài)性主要表現(xiàn)為戒斷癥狀，精神依賴(lài)性則是藥物對(duì)中樞神經(jīng)系統(tǒng)作用后所產(chǎn)生的一種特殊的獎(jiǎng)賞效應(yīng)，表現(xiàn)為心理渴求和持續(xù)精神焦慮、抑郁障礙；而精神依賴(lài)性是導(dǎo)致復(fù)吸的重要原因，同時(shí)持續(xù)心理渴求、精神抑郁障礙又嚴(yán)重影響吸毒者的心理健康和人格健全。 海洛因依賴(lài)者脫毒期抑郁癥屬于藥物引發(fā)的繼發(fā)性抑郁障礙，但目前大多數(shù)治療方法仍然采用抗抑郁藥物為主的治療方法，另外也有采用心理認(rèn)知療法、中醫(yī)中藥等，雖然一定程度上在緩解海洛因依賴(lài)者脫毒期抑郁及心理渴求癥狀，但療效反復(fù)，，臨床治愈率低。 本研究采用神經(jīng)生長(zhǎng)因子(nerve growth factor NGF）聯(lián)合西酞普蘭的治療方式,從神經(jīng)心理學(xué)角度積極探索治療海洛因依賴(lài)者脫毒期抑郁癥的有效方法，分析其心理渴求、抑郁癥狀的可能發(fā)病原因和發(fā)病機(jī)制，并為今后的戒毒治療提供參考。 目的： 評(píng)價(jià)神經(jīng)生長(zhǎng)因子聯(lián)合西酞普蘭對(duì)海洛因依賴(lài)者的抑郁及心理渴求癥狀的治療效果。 方法： 將93名男性患者隨機(jī)分為兩組，其中西酞普蘭治療組41人，神經(jīng)生長(zhǎng)因子(NGF）聯(lián)合西酞普蘭治療組42人，治療前兩組罪犯的年齡、刑期及Beck抑郁自評(píng)問(wèn)卷(BDI-13)評(píng)分比較均無(wú)統(tǒng)計(jì)學(xué)差異。除戒毒用藥美沙酮及丁丙諾啡外，兩組分別應(yīng)用西酞普蘭和神經(jīng)生長(zhǎng)因子聯(lián)合西酞普蘭進(jìn)行治療，療程為6周。采用Beck抑郁自評(píng)問(wèn)卷(BDI-13)、心理渴求自評(píng)量表及臨床療效總評(píng)量表(CGI)進(jìn)行評(píng)定療效。 結(jié)果： 神經(jīng)生長(zhǎng)因子聯(lián)合西酞普蘭組治療后1、2、4、6周末BDI-13評(píng)分及減分率較西酞普蘭組有明顯差異(P0.05)；神經(jīng)生長(zhǎng)因子聯(lián)合西酞普蘭組治療后14、21、28、35、42天末心理渴求評(píng)分較西酞普蘭組明顯下降(P0.05)：神經(jīng)生長(zhǎng)因子聯(lián)合西酞普蘭組治療后1、2、4、6周末臨床療效總評(píng)量表(CGI)評(píng)分較西酞普蘭組明顯減少(P0.05)。 結(jié)論： 神經(jīng)生長(zhǎng)因子聯(lián)合西酞普蘭可有效地減輕海洛因依賴(lài)者在脫毒期抑郁及心理渴求癥狀。
[Abstract]:It is reported that about 100000 people die from drug abuse every year in the world, and about 1 million drug addicts are registered in our country. After repeated use of morphine, heroin and other drugs, they will produce physical and mental dependence, which is mainly manifested as withdrawal symptoms. Mental dependence is a special reward effect after the effect of drugs on the central nervous system, which is manifested by psychological craving, persistent mental anxiety and depression, and mental dependence is an important cause of relapse. At the same time, persistent psychological craving and mental depression seriously affect the mental health and personality of drug addicts. Detoxifying detoxification of heroin addicts is a secondary depressive disorder caused by drugs. However, at present, most of the treatment methods still use antidepressants as the main treatment methods, in addition, they also use psychological cognitive therapy, traditional Chinese medicine, and so on. Although the depressive and psychological craving symptoms in detoxified heroin addicts were alleviated to some extent, the curative effect was repeated and the clinical cure rate was low. In this study, nerve growth factor combined with citalopram was used to explore the effective treatment of detoxified depression in heroin addicts from the perspective of neuropsychology, and to analyze their psychological craving. The possible causes and pathogenesis of depressive symptoms, and provide reference for the future treatment of detoxification. Aim: to evaluate the effect of nerve growth factor (NGF) combined with citalopram on depression and craving symptoms in heroin addicts. Methods: 93 male patients were randomly divided into two groups: 41 in citalopram group and 42 in NGF combined with citalopram group. There was no significant difference in prison term and BDI-13 score in Beck self-assessment depression questionnaire. In addition to methadone and buprenorphine, the two groups were treated with citalopram and nerve growth factor combined with citalopram for 6 weeks. The efficacy was evaluated by Beck self-rating depression questionnaire BDI-13 psychological craving scale and General efficacy scale (CGI). Results: the BDI-13 score and score reduction rate of NGF combined with citalopram group were significantly different from those of citalopram group at the end of 6 weeks. The scores of craving at the end of 42 days in the NGF combined with citalopram group were significantly lower than those in the citalopram group at the end of 42 days. The CGI scores of NGF combined with citalopram group at the end of the week were higher than those in the citalopram group at the end of the week. In the group of Plain, the concentration of P0. 05 was significantly decreased. Conclusion: NGF combined with citalopram can effectively relieve detoxification depression and craving symptoms in heroin addicts.
【學(xué)位授予單位】：安徽醫(yī)科大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2013
【分類(lèi)號(hào)】：R749.6

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 全東明,葉敏書(shū),林海程,郭光全,李剛,劉珍妮,劉武漢;海洛因依賴(lài)者醫(yī)學(xué)應(yīng)對(duì)方式及相關(guān)因素[J];中國(guó)藥物依賴(lài)性雜志;2005年04期

2 劉道楚;;多慮平對(duì)140例海洛因依賴(lài)者脫毒期的焦慮、心理渴求的療效分析[J];廣西醫(yī)學(xué);2008年04期

3 劉曉偉,季慶,王進(jìn)良,陳彩霞,戴強(qiáng),曹磊明;西酞普蘭治療腦卒中后抑郁對(duì)照研究[J];臨床精神醫(yī)學(xué)雜志;2004年02期

4 高振忠,徐廣軍,于建軍;西酞普蘭與氟西汀治療抑郁癥的臨床對(duì)照研究[J];中國(guó)行為醫(yī)學(xué)科學(xué);2004年03期

5 劉曉偉,曹磊明,戴強(qiáng),王進(jìn)良,楊國(guó)平;西酞普蘭治療廣泛性焦慮對(duì)照研究[J];臨床精神醫(yī)學(xué)雜志;2004年06期

6 張文霞;邢玉芹;姜燕;;西酞普蘭致血小板減少癥1例報(bào)告[J];四川精神衛(wèi)生;2011年03期

7 姚芳傳;西酞普蘭對(duì)恐懼癥和強(qiáng)迫癥的療效——讀者來(lái)信[J];臨床精神醫(yī)學(xué)雜志;2003年02期

8 余新良;西酞普蘭治療抑郁癥68例[J];現(xiàn)代醫(yī)藥衛(wèi)生;2003年10期

9 譚新國(guó),李會(huì)香,杜志廣,王強(qiáng),趙玉香,封曉朋;西酞普蘭和阿米替林治療老年抑郁癥的雙盲對(duì)照研究[J];山東精神醫(yī)學(xué);2004年04期

10 唐偉;西酞普蘭治療抑郁性障礙臨床觀察[J];臨床精神醫(yī)學(xué)雜志;2004年06期

相關(guān)會(huì)議論文 前10條

1 王丹逢;麥桂英;伍遠(yuǎn)菲;藍(lán)曉嫦;朱海兵;;艾司西酞普蘭早期起效與血藥濃度的關(guān)系[A];中華醫(yī)學(xué)會(huì)精神病學(xué)分會(huì)第九次全國(guó)學(xué)術(shù)會(huì)議論文集[C];2011年

2 商學(xué)軍;夏欣一;黃宇烽;;西酞普蘭治療早泄的臨床觀察[A];第七次全國(guó)中西醫(yī)結(jié)合男科學(xué)術(shù)會(huì)議及全國(guó)中西醫(yī)結(jié)合男科提高班論文匯編及講義[C];2011年

3 黃承繁;;西酞普蘭治療帕金森病伴發(fā)抑郁對(duì)照研究[A];中華醫(yī)學(xué)會(huì)精神病學(xué)分會(huì)第九次全國(guó)學(xué)術(shù)會(huì)議論文集[C];2011年

4 宮國(guó)華;于麗君;包桂蘭;魏成喜;;氫溴酸西酞普蘭導(dǎo)致多種癲癇小鼠的致命毒性[A];2011年全國(guó)藥物化學(xué)學(xué)術(shù)會(huì)議——藥物的源頭創(chuàng)新論文摘要集[C];2011年

5 李磊;張向榮;張志s

本文編號(hào)：2047832